Not finding it? Sign in to also search OpenAlex live.
-
Time-dependent effects of positive end-expiratory pressure on hemodynamics, respiratory mechanics and clinical outcomes in patients receiving veno-arterial extracorporeal membrane oxygenation
Ilaria Protti, Myrthe P. J. van Steenwijk, Lara C. A. Pladet, Atreyu van Esch, Giacomo Grasselli, Nicole Petra Juffermans, +16 more
0citations -
Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant2025 The Breast article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Maartje A. C. Schreurs, Muriel A. Adank, Bernadette A. M. Heemskerk‐Gerritsen, Antoinette Hollestelle, Nyrée Smallenbroek, Christie J. van Asperen, +11 more
0citations -
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial2020 British Journal of Cancer article Medicine Chemotherapy-induced cardiotoxicity and mitigation Open access
Daniel Eiger, Noam Falbel Ponde, Dominique Agbor‐Tarh, Alvaro Moreno‐Aspitia, Martine J Piccart, Florentine Hilbers, +10 more
42citations -
Oncological outcomes and treatment characteristics of patients with cT3-4 mesorectal fascia positive rectal cancer operated in 2016: Dutch nationwide cohort with standardized magnetic resonance imaging re-assessment
Julie E E A Guicherit, Eline G M van Geffen, Tania C. Sluckin, Sanne-Marije J.A. Hazen, Jacobus W A Burger, Joost Nederend, +93 more
0citations -
The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node–positive melanoma without the need for completion lymph node dissection2020 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Daniëlle Verver, Alexandros Rekkas, Claus Garbe, David V. Klaveren, Alexander C. J. van Akkooi, Piotr Lukasz Rutkowski, +11 more
23citations -
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial
Ulrike Anneliese Nitz, Oleg Gluz, Monika Graeser, Matthias Christgen, Sherko Küemmel, Eva‐Maria Grischke, +43 more
93citations -
Abstract P2-17-01: Therapy of advanced breast cancer for patients with hormone receptor-positive/HER2-negative and HER2-positive tumors is changing in real life: First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Elmar Stickeler, Nadia Harbeck, Marc Thill, Arnd Nusch, Marco Chiabudini, Lisa Kruggel, +6 more
0citations -
Abstract PO1-04-12: Palbociclib versus ribociclib in first-line treatment of patients with hormone-receptor positive HER2 negative advanced breast cancer – real world outcome data from the German registry platform OPAL
Marc Thill, Mark‐Oliver Zahn, Anja Welt, Arnd Nusch, Matthias R. Zaiss, Kathrin Engelken, +11 more
7citations -
Abstract PS10-07: Pathologic complete response and 3-year survival with or without pertuzumab using real-world data of stage II and III HER2-positive breast cancer
Anna van der Voort, Marte C. Liefaard, Mette van Ramshorst, Erik D. van Werkhoven, Astrid N. Scholten, Jelle Wesseling, +3 more
0citations -
Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer2022 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sonja B. Vliek, Florentine Hilbers, Agnes Jager, Valesca P. Retèl, J.M. Bueno de Mesquita, Caroline A. Drukker, +8 more
13citations -
Abstract GS4-09: Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13)2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Ann Partridge, Olivia Pagani, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro Peccatori, Hatem A. Azim, +30 more
9citations -
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial2022 The Lancet Diabetes & Endocrinology article Medicine Thyroid Disorders and Treatments Open access
Marie‐Louise van der Hoorn, Ole Bjarne Christiansen, Madelon van Wely
95citations